SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,870,000 | -27.9% | 11,007 | -51.5% | 0.13% | -15.0% |
Q4 2019 | $2,592,000 | +82.0% | 22,682 | +16.6% | 0.15% | +51.5% |
Q1 2019 | $1,424,000 | +14.0% | 19,447 | +3.3% | 0.10% | +16.1% |
Q2 2018 | $1,249,000 | +6.5% | 18,817 | -16.0% | 0.09% | +6.1% |
Q1 2018 | $1,173,000 | +26.0% | 22,406 | +28.8% | 0.08% | -19.6% |
Q4 2017 | $931,000 | +311.9% | 17,397 | +318.3% | 0.10% | +78.9% |
Q3 2017 | $226,000 | -31.1% | 4,159 | -20.3% | 0.06% | +35.7% |
Q1 2017 | $328,000 | -47.5% | 5,218 | -66.3% | 0.04% | -48.8% |
Q2 2016 | $625,000 | -52.8% | 15,469 | -47.5% | 0.08% | -29.9% |
Q4 2015 | $1,323,000 | +60.4% | 29,480 | +37.8% | 0.12% | +64.8% |
Q3 2015 | $825,000 | +42.5% | 21,400 | +30.5% | 0.07% | +20.3% |
Q1 2015 | $579,000 | -33.7% | 16,400 | -39.7% | 0.06% | -61.7% |
Q4 2014 | $873,000 | – | 27,200 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |